ERAS-007 - Erasca
Erbitux (cetuximab) - Eli Lilly
Braftovi (encorafenib) - Pfizer
Ibrance (palbociclib) - Pfizer
http://clinicaltrials.gov/ct2/show/NCT05039177
 
Mar 26, 2026
 
Prev Next